Peak Proteins Blog Archives
From In Silico to In Vivo: Keeping AI honest in drug development
AI is undeniably transforming drug discovery: from pinpointing promising disease targets to sketching drug-like molecules, flagging safety risks, and streamlining workflows that once took months into days. The story started from early QSAR models, through the deep-learning boom of [...]
